Molecular Predictors of Immunophenotypic Measurable Residual Disease Clearance in AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
Am. J. Hematol 2022 Oct 17;[EPub Ahead of Print], M Stahl, A Derkach, N Farnoud, JP Bewersdorf, T Robinson, C Famulare, C Cho, S Devlin, K Menghrajani, MA Patel, SF Cai, LA Miles, RL Bowman, MB Geyer, A Dunbar, ZD Epstein-Peterson, E McGovern, J Schulman, JL Glass, J Taylor, AD Viny, EM Stein, B Getta, ME Arcila, Q Gao, J Barker, BC Shaffer, EB Papadopoulos, B Gyurkocza, MA Perales, O Abdel-Wahab, RL Levine, SA Giralt, Y Zhang, W Xiao, N Pai, E Papaemmanuil, MS Tallman, M Roshal, AD GoldbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.